Clinical Trials Directory

Trials / Completed

CompletedNCT00677378

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

Capsaicin-sensitive Transient Receptor Potential Vanilloid One (TRPV1) and Tyrosine Kinase (TrkA) Receptor Expression in Children With Retrosternal Pain

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

Detailed description

Approximately 5% of children between 10-17 years of age report symptoms of heart burn, epigastric pain or regurgitation. This study will evaluate the changes in nerve innervation and TRPV1 receptor expression in children having upper endoscopy for evaluation of heart burn and abdominal pain.

Conditions

Timeline

Start date
2006-12-01
Primary completion
2014-12-01
Completion
2015-10-01
First posted
2008-05-14
Last updated
2015-10-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00677378. Inclusion in this directory is not an endorsement.

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain (NCT00677378) · Clinical Trials Directory